Objectives Inbreeding increases the probability of homozygosity of deleterious alleles. Inbreeding and runs of homozygosity (ROH) are associated with an increased risk for disease phenotypes, including schizophrenia and other psychiatric disorders. The effects of inbreeding, ROH, homozygous deletions, and other copy number variations (CNVs) on risk for depression and suicide attempt (SA) were quantified in an Arab Bedouin Kindred.
Objectives Inbreeding increases the probability of homozygosity of deleterious alleles. Inbreeding and runs of homozygosity (ROH) are associated with an increased risk for disease phenotypes, including schizophrenia and other psychiatric disorders. The effects of inbreeding, ROH, homozygous deletions, and other copy number variations (CNVs) on risk for depression and suicide attempt (SA) were quantified in an Arab Bedouin Kindred.
Methods We carried out genetic analyses of 439 individuals from an Arab kindred with high rates of depression and suicidal behavior. We obtained complete ascertainment of SAs and first-degree relatives of individuals who have attempted or died by suicide.
Results We found extensive regions of ROH. On average, 5% of the genome is covered by ROH for these individuals, two-fold higher than ROH rates for individuals from populations of European ancestry. Inbreeding and total length of ROH were not associated with risk for depression or attempt. For CNVs, an increased number of duplications more than 500 kb was associated with an increased risk for attempt (odds ratio: 2.9; P = 0.01; 95% confidence interval: 1.3-6.6). Although not significant after correction for multiple testing, the risk for SA appears to increase with copy number for a CNV on chromosome 9p24.1.
This possibility is intriguing because the CNV covers GLDC, which encodes glycine dehydrogenase that binds to glycine, a co-agonist at N-methyl-D-aspartate glutamate receptors, and is involved in glutamatergic neurotransmission.
Conclusion
Our findings add to the growing evidence of genetic risk factors that act pleiotropically to increase the risk for several neuropsychiatric disorders, including depression and SA, irrespective of ancestry. Psychiatr Genet 27:169-177 Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
Introduction
The risk for depression and suicidal behavior, like most psychiatric disorders, has a complex genetic and environmental basis. Myriad genetic factors are involved; most have only a small effect on risk and they potentially have different modes of inheritance. For all these reasons, it has proven difficult to identify individual risk variants and, arguably, different study designs will prove effective in identifying certain risk variants. One successful approach arises from the growing evidence that genetic risk factors are shared across neuropsychiatric disorders. Genome-wide association studies from the Cross-Disorder Group of the Psychiatric Genomics Consortium (2013); Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) and others (Malhotra and Sebat, 2012) have identified common variants that are associated with an increased risk of a range of neuropsychiatric disorders including major depression, attention deficit hyperactivity disorder, bipolar disorder, schizophrenia, autism, and intellectual function. Parallel results arise from copy number variant (CNV) studies. The largest study examining the role of CNVs in recurrent depression included 3106 cases and 6078 controls; it found evidence for association with CNVs such as 1q21.1, 15q13.3, and 22q11.2, when both duplications and deletions were considered together (Rucker et al., 2013) . Although the burden of rare CNVs more than 100 kb was not associated with recurrent depression, cases showed significantly higher Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website (www.psychgenetics.com).
number of genes falling within deletion CNVs compared with controls (Rucker et al., 2016) . The combination of microdeletions and microduplications in 16p11.2 was also associated with major depressive disorder (Degenhardt et al., 2012) . To varying degrees, these CNVs have been associated previously with autism, schizophrenia, and intellectual disability (Malhotra and Sebat, 2012) . In addition, a novel duplication in SLIT3 on 5q35.1 was reported in depression (Glessner et al., 2010) .
Pedigree studies have proven highly useful for identifying risk variants underlying Mendelian disorders, but so far, they are less effective for psychiatric and other complex disorders. Nonetheless, there are exceptions, such as the classic study of a DISC1/Boymaw variant segregating with schizophrenia, bipolar disorder, and depression in a large family (St Clair et al., 1990; Zhou et al., 2008) . CNVs falling in neuronal genes have been found to be enriched in cases in an Amish pedigree segregating bipolar and major depressive disorders (Yang et al., 2009) . A study using a 5-generation Palauan family showed segregation of a deletion of SLC1A1 glutamate transporter with schizophrenia and bipolar disorder (Myles-Worsley et al., 2013) .
Homozygosity mapping has also been successful in identifying recessive risk variants for disorders showing Mendelian inheritance (Ekstein et al., 2004; Fares et al., 2008) , and examples of successful mapping are also emerging for some complex psychiatric disorders, such as autism (Gamsiz et al., 2013; Lim et al., 2013; Yu et al., 2013) . There is an increased interest in runs of homozygosity (ROH), given evidence of their association with increased risk for schizophrenia and other psychiatric disorders Keller et al., 2012; Gamsiz et al., 2013) . Consistent with the population genetic theory, human inbreeding results in longer ROH and potentially shows a greater number of deleterious recessive alleles (Kirin et al., 2010; Szpiech et al., 2013) . Direct inbreeding, through consanguineous marriages, has been associated with an increased risk for schizophrenia and bipolar disorder in Egypt, Iran, and Arab Bedouin populations (Dobrusin et al., 2009; Mansour et al., 2009 Mansour et al., , 2010 Nafissi et al., 2011; Saadat, 2012) , and increased risk for suicide by self-inflicted burning in Iran (Saadat and Zendeh-Boodi, 2006) . Homozygosity mapping of recurrent major depression in a large extended family in Pakistan with a high rate of consanguineous marriages showed significant linkage on chromosomes 6 and 9 (Ayub et al., 2013) .
Inbreeding is common in the Arab world in general and among Bedouins in particular (Jaber et al., 1994; Teebi and Farag, 1997) . The Arab world is a mixture of ethnically heterogeneous populations and is the result of admixture with other populations such as Persians, Turks, Southeast Asians, Europeans, and Africans (Teebi and Farag, 1997) . In addition to the ethnically heterogeneous populations, homogeneous populations, or isolates, also exist. These include Bedouins, originally from Saudi Arabia or Iraq, who usually belong to tribes and can trace their ancestry to few founders.
Here, we report on a large Arab Bedouin kindred to examine whether inbreeding and resultant longer ROH are related to the high levels of depression and suicidal behavior observed in this kindred. The pedigree consists of 1183 individuals across five generations who can trace their ancestry to a single pair of founders, as well as individuals who are married in. The suicide attempt (SA) rate in this pedigree is 9.1%, much higher than that reported in Lebanon (2%), the USA (5%), and the crossnational prevalence rate across 17 (2.7%) countries (Nock et al., 2008; Hamdan et al., 2012) . Similarly, this kindred has a high rate of lifetime depression (25.7%) compared with Lebanon (10.8%), the USA (17.9%), and the crossnational prevalence rate across 17 (11.6%) countries (Kovess-Masfety et al., 2013) . Complete ascertainment of SAs and all first-degree relatives of individuals who have completed or attempted suicide was sought. In addition to ROH, the impact of CNVs on risk was also evaluated.
Methods

Sample
We constructed the pedigree in collaboration with a liaison of the village and sought complete ascertainment of SAs and all first-degree relatives of individuals who have died by or attempted suicide. A trained Arab-speaking clinical psychologist (S.H.) directly interviewed study participants and verified the pedigree connections after obtaining informed consent from the participant and their legal guardian for participants 14 to 17 years of age. Research protocols and procedures were approved by Institutional Review Boards at the University of Pittsburgh and Schneider Children's Hospital. Participants were interviewed using the Arabic version of the World Mental Health-Composite International Diagnostic Interview (Demyttenaere et al., 2004; Kessler and Ustun, 2004; Karam et al., 2006) A total sample of 439 individuals participated in the study and provided a blood sample. The acceptance rate for study participation was 94%. The sample was almost equally distributed with respect to sex, 54.7% were female (240 females and 199 males), and the mean age of the participants was 27.1 years (SD = 11.5, range: 14-59). There were 159 (36.2%) affected individuals: 113 (25.7%) had a lifetime diagnosis of depression, 40 (9.1%) had made at least one SA, 117 (26.7%) had anxiety disorder, six (1.4%) had schizophrenia, and three (0.7%) had bipolar disorder (Table 1 ). There were 240 individuals unaffected by any of these disorders and 40 individuals with an unknown diagnosis. Of the 40 participants with a history of SA, 28 had a lifetime diagnosis of depression, six had schizophrenia, five had anxiety disorder, and one had post-traumatic stress disorder. Of the 113 participants with depression, 67% also had an anxiety disorder. In this study, we focused on the narrow phenotype of SA and the broad phenotype of suicide attempt and/or depression (SA-DEP) (n = 125, 28.5%).
Estimating inbreeding coefficient
The inbreeding coefficient was computed on the basis of genotyping data of 401 short tandem repeats (STRs) from prevention genetics for all 439 participants after performing quality control at the individual and marker level. We also checked for Mendelian errors using PedCheck (O'Connell and Weeks, 1998). We excluded 19 (4.3%) samples with less than 90% call rate and 29 (7.2%) STR markers on the basis of the distribution of missingness and Mendelian errors. There were two (0.4%) discrepancies between the genotype-based sex and the pedigree information on the basis of chromosome Y markers, which were errors on the pedigree and were corrected. Genetic relationships were estimated using all markers and pairwise identity-by-descent relationships for all pairs of samples were estimated using maximum likelihood. Identity-by-descent estimates for different pedigree relationships (parent-offspring, full siblings and half-siblings, unrelated) were examined and outliers were identified and investigated. We examined the relationship between genetic-based estimates of inbreeding and risk for the narrow and broad phenotypes using linear regression analyses and computing SEs for parameter estimates using the cluster option in Stata (Stata Corp., College Station, Texas, USA), which allows for correlations within nuclear families.
Runs of homozygosity
We genotyped 177 out of the 439 samples using Affymetrix Genomewide Human single-nucleotide polymorphism (SNP) Array 6.0, which resulted in 909 622 SNPs. We prioritized multiplex nuclear families, with more than one family member affected with any psychiatric disorder, and genotyped all affected and unaffected members. We excluded monomorphic SNPs (15 859 SNPs) and SNPs on the basis of the distribution of missingness (4778 SNPs with < 97% call rate) and Mendelian errors (57 527 SNPs with > 1 error). We also excluded seven (3.9%) samples on the basis of the distribution of missingness by sample with less than 99.7% call rate. Analyses were carried out with 170 (84 affected, 83 unaffected, and three with unknown diagnosis) participants and 832 308 SNPs. We used Plink (Purcell et al., 2007) and Affymetrix 6.0 genotype data to evaluate ROH on autosomes on the basis of the following settings: a sliding window of 2 Mb; an ROH consisted of at least 100 consecutive homozygous SNPs, with no heterozygotes allowed, but up to two missing genotypes were allowed; the density specified is a minimum of one SNP per 50 kb; and the maximum allowed gap between SNPs in an ROH region was 2 Mb. The last criterion was chosen to prevent ROH spanning the centromere. We compared cases, on the basis of the narrow (SA, n = 32) and broad (SA-DEP, n = 66) phenotypes, and controls unaffected by any psychiatric disorder (n = 83) on the total length of ROH across the genome using linear regression taking into account the clustering within nuclear families (Table 1) .
Copy number variation analyses
CNVs were called using genotype image intensities and two different calling algorithms: Birdseye of the Birdsuite package (Korn et al., 2008) and PennCNV (Wang et al., 2007) . Genotype-based sex was supplied for calling CNVs on X. CNVs were called only when covered by 20 or more SNPs or monomorphic markers (henceforth called 'probes'). Within this sample and according to Birdsuite, the average count of CNVs per sample was 51; the average size of a CNV was 74.3 kb; and an average CNV was called using 51 probes. According to PennCNVs, the average count of CNVs per sample was 38; the average size of a CNV was 109.5 kb; and an average CNV was called using 58 probes. We analyzed were unaffected by any psychiatric disorder, and six had an unknown diagnosis (Table 1) . We compared SA (n = 31) and controls (n = 75) as well as SA-DEP (65) and controls (n = 75) on total CNV burden, duplications, deletions, and homozygous deletions called by Birdsuite and PennCNV using logistic regression and taking into account the clustering within nuclear families. Similar analyses from the International Schizophrenia Consortium (2008) and others (Kirov et al., 2009; Malhotra and Sebat, 2012) were carried out for CNVs larger than 500 kb, which are implicated in an increased risk for schizophrenia and other neuropsychiatric disorders.
Copy number variation molecular validation
We identified CNVs nominally associated with an increased risk for SA-DEP in this sample, as measured by the odds ratio (OR), and occurring in genes of relevance to psychiatric disorders, typically identified in studies of samples of European ancestry. We examined the association of these CNVs with affecting status using logistic regression and taking into account clustering within families. OR and 95% confidence interval (CI) are reported. When there is a zero cell (undefined or infinity OR), we used the Firth penalized likelihood method (Firth, 1993) . Given the relatively small sample size of this study, we do not expect the association of these CNVs with diagnosis to be statistically significant.
We considered risk CNVs for molecular validation if they were called by both Birdsuite and PennCNV algorithms and if they segregated in nuclear families with disorder. We used Nanostring's nCounter (Nanostring Technologies, Redwood, California, USA) Custom CNV technology to validate risk CNVs in carriers identified on the basis of the two algorithms. We ran Nanostring on 376 out of the 439 samples, which included all samples genotyped with Affymetrix 6.0 (Thermo Fisher Scientific, Waltham, Massachusetts, USA), all remaining affected participants, and all remaining controls for whom there remained sufficient DNA. The Nanostring's nCounter Custom CNV CodeSets included six positive control probes, eight negative control probes, 10 invariant probes designed to autosomal genomic regions that do not cover common CNVs, restriction site controls, and endogenous probes designed to risk CNV regions identified (Supplementary Table S1 (Table 1) . We normalized the data to the invariant probes and used a CEPH sample as a reference sample to calculate copy number estimates for each probe. For the selected risk CNV regions, we used finite normal mixture modeling for model-based clustering and classification (mclust in R) to identify samples with duplications and deletions. Only probes with a normal distribution of copy number estimates, as evidence of good quality probes, were included in the analyses. Finally, we extracted expression Quantitative Trait Loci (eQTLs) in the cerebellum and parietal regions of the brain from the SNP and CNV Annotation Database (SCAN) for genes falling in CNV regions with an increased risk for SA-DEP. We examined the association of the resulting eQTLs with depression in the Psychiatric Genetics Consortium database (Ripke et al., 2013) .
Results
Inbreeding
By analysis of 372 STR genotypes per participant, the estimated average inbreeding coefficient ƒ for participants in this kindred was 0.021 (SD = 0.03, range: 0-0.157). This estimate falls between that expected from the marriage between second cousins (ƒ = 0.0156) and first cousins (ƒ = 0.0625). Only 11% of participants have ƒ of at least 0.0625 ( Supplementary Fig. S1 , Supplemental digital content 1, http://links.lww.com/PG/A192). We found no significant relationship between inbreeding and SA (β = − 0.001; P = 0.78; 95% CI: − 0.01-0.008) or between inbreeding and SA-DEP (β = 0.003; P = 0.54; 95% CI: − 0.006-0.011).
Runs of homozygosity
On average, participants carried 212.4 (SD = 69.7, range: 8-445) ROH regions, with an average length per region of 712.3 kb (SD = 257.3, range: 406.3-1577.4). The average total ROH length is 160.7 Mb (SD = 92.9, range: 3.4-400.6) ( Supplementary Fig. S2 , Supplemental digital content 1, http://links.lww.com/PG/A192). The inbreeding coefficient was significantly correlated with the number of ROH regions (r = 0.573, P < 0.001), average length of an ROH (r = 0.555, P < 0.001), and total length of ROH (r = 0.664, P < 0.001). As expected, the total length of ROH across the genome was highly correlated with the number of ROH regions (r = 0.819, P < 0.001) and the average length of an ROH (r = 0.905, P < 0.001). The total length of ROH was not significantly different between cases and controls for either the broad (167.5 11.1 vs. 159.2 11.3; β = 9.4; t = 0.60; P = 0.55; 95% CI: − 21.6-40.4) or the narrow phenotype (156.9 16.4 vs. 159.2 11.3; β = − 0.36; t = − 0.02, P = 0.99; 95% CI: − 40.6-39.9) ( Supplementary Fig. S2 , Supplemental digital content 1, http://links.lww.com/PG/A192).
Copy number variation burden
The average number of CNVs, duplications, and deletions per participant is 25.4 (SD = 5.8), 6.4 (SD = 2.9), and 13.8 (SD = 4.1), respectively ( Supplementary Fig. S3 , Supplemental digital content 1, http://links.lww.com/PG/ A192). Participants had on average 5.3 (SD = 2) homozygous deletions ( Supplementary Fig. S4 , Supplemental digital content 1, http://links.lww.com/PG/A192). Looking at CNVs larger than 500 kb, participants had an average 1.8 CNVs (SD = 1), 1.5 (SD = 0.7) duplications, and 1.3 (SD = 0.8) deletions ( Supplementary Fig. S5 , Supplemental digital content 1, http://links.lww.com/PG/A192). None of the participants genotyped on Affymetrix 6.0 carried homozygous deletions larger than 500 kb. Large duplications were significantly associated with an increased risk for SA (OR: 2.9; P = 0.01; 95% CI: 1.3-6.6) ( Fig. 1) and SA-DEP (OR: 2.1; P = 0.02; 95% CI: 1.1-3.9).
Copy number variation molecular validation
We detected several CNVs in this Bedouin kindred that could confer risk to depression, SA, and related disorders, as measured by the OR (Supplementary Table S2 , Supplemental digital content 1, http://links.lww.com/PG/A192).
The largest CNV is a 1.4 Mb duplication on chromosome 17p12-p13.1 observed in one male participant who had attempted suicide and was diagnosed with depression and anxiety. This duplication spanning 14-15.4 Mb covered several genes including PMP22, duplication of, or mutation in PMP22 causes Charcot-Marie-Tooth disease, type 1A (OMIM#118220), a neuropathy characterized by progressive loss of muscle tissue and touch sensation. The duplication was called by Birdsuite and PennCNV algorithms and molecularly validated in this participant. None of the samples analyzed with Nanostring showed this duplication.
We also identified duplications and deletions in 9p24.1 covering two genes: UHFR2 and GLDC ( Supplementary   Fig. S6 , Supplemental digital content 1, http://links.lww. com/PG/A192). The duplication is associated with an increased risk on the basis of the OR (OR: 5.4; 95% CI: 0.6-49.4), but not the deletion (OR: 0.5; 95% CI: 0.12-1.72). However, when we examined the number of copies of this CNV, we found a significantly increased risk for SA with increased copy numbers (OR: 13.1; P = 0.021; 95% CI: 1.5-115.5), which remained significant after controlling for sex. The duplication, ∼ 193 kb (chr9: 6 484 504-6 676 585), occurred in two affected full sibling females, two affected half-siblings resulting from consanguineous marriages (one male and one female), one affected female from a consanguineous marriage, one unaffected female, and one female with an unknown diagnosis (Fig. 2) . All CNV carriers were related among each other. The duplication in all affected participants was called by both CNV algorithms and was molecularly validated, except in one participant where we could not validate it because of poor sample quality on Nanostring (Supplementary Table S3 , Supplemental digital content 1, http://links.lww.com/PG/A192). The unaffected participant and the one with an unknown diagnosis were not genotyped on Affymetrix 6.0, but were detected on Nanostring. The duplication, if it confers risk, is incompletely penetrant; however, the unaffected participant and the one with an unknown diagnosis were both 21 years of age at the time of assessment and thus not yet through the age of risk for depression and SA. We have previously shown that incident suicidal behavior continues to occur up to the age of 30 years (Melhem et al., 2007) . We have also shown that the risk and protective factors for suicidal behavior in this Number of CNVs >500 Kb
Percent
Distribution of large duplications (>500 kb) in all participants, cases, and controls on the basis of suicide attempt. CNV, copy number variation.
Genetic risk factors for suicidal behavior Melhem et al. 173 kindred are similar to those in European populations (Hamdan et al., 2012) . For the most proximal and distal boundaries of the 9p24.1 CNV in our study (chr9: 6 484 504-6 676 585), a search of the Database of Genomic Variants (Iafrate et al., 2004) with 18 294 healthy participants found 96 CNVs, of which 26 (27 or 0.14% of the total number of healthy participants) actually fall within the GLDC gene compared with eight out of the 78 (10.3%) affected participants in our sample. Of the 26 Database of Genomic Variant CNVs falling in GLDC, there were 13 that covered intronic regions of the gene, 11 covered 1-3 exons, and 2 covered 14-15 exons. All CNV carriers in our sample had duplication or deletion of the full GLDC gene with all of its 25 exons.
Looking at eQTLs from the SCAN SNP and CNV annotation database, we found two out of 31 eQTL (21 cis and 10 trans) SNPs for GLDC in the parietal region of the brain, rs4363822 (trans-eQTL P = 1.87 × 10
) and rs997295 (trans-eQTL P = 1.91 × 10 − 6 ), which were associated with depression in the PGC dataset with P values of 6 × 10 − 3 and 6.3 × 10 − 3 , respectively. These were on chromosome 15 at positions (hg18) 65 779 637 and 65 803 397 bp, respectively, and they fell in MAP2K5. Five other GLDC eQTLs in the parietal region showed P values between 0.01 < P < 0.05 for associations with depression in the PGC dataset. There were 87 cis-eQTLs for GLDC in the cerebellum, of which 10 SNPs showed P values between 0.01 < P < 0.05 for associations with depression in the PGC dataset.
Other CNVs were found that could increase the risk for our phenotypes according to their OR (Supplementary  Tables S4-S8 , Supplemental digital content 1, http://links.lww. com/PG/A192 Supplementary Figs S7-S16, Supplemental digital content 1, http://links.lww.com/PG/A192). These included an exonic deletion in 3p11.2-p11.1 covering EPHA3, an exonic duplication in 6q21 covering HACE1, an intronic duplication in 8p12 covering NRG1, an exonic duplication in 10q26.3 covering CYP2E1, and an exonic duplication and deletion in 16p13.11.
Discussion
In this Arab Bedouin kindred, we find extensive regions of homozygosity, consistent with other Arab populations with similar rates of inbreeding (Hunter-Zinck et al., 2010) . On average, 5% of the genome is covered by ROH for participants from this kindred, two-fold higher than ROH rates for participants from populations of European ancestry (McQuillan et al., 2008) . However, this is consistent with ROH in isolated endogamous Berber groups from North African populations consisting of an admixture of sub-Saharan, North African, European, and Middle Eastern ancestral components (Arauna et al., 2017) .
Previous studies show inbreeding to be associated with an increased risk of schizophrenia, bipolar disorder, and suicidal self-inflicted burns in Egypt, Iran, and Bedouin populations (Saadat and Zendeh-Boodi, 2006; Dobrusin et al., 2009; Mansour et al., 2009 Mansour et al., , 2010 Nafissi et al., 2011; Saadat, 2012) . However, we did not find estimated level of inbreeding to be associated with increased risk for depression and SA in this kindred. Although our study is limited with respect to characterizing the genotyped sample on other diseases, the effects of inbreeding for other diseases are evident in this kindred where several diseases with a recessive mode of inheritance occur including limb girdle muscular dystrophy, thalassemia, Pedigree relationships between participants carrying the 9p24.1 duplication. Some of the deletion carriers belong to this pedigree and are indicated. Participants in black are affected; participants in grey have an unknown diagnosis. DEL, deletion; DUP, duplication.
von Willebrand disease, hereditary sensory and autonomic neuropathy, and congenital motor nystagmus (Farbstein E., personal communication). Thus, this kindred is similar to Arab populations and specifically, Palestinians, in their increased rates of recessive diseases (Zlotogora, 2002 (Zlotogora, , 2010 . It is possible that the lack of association between inbreeding and risk for depression and SA could be an attribute of the genetic structure of this kindred and founder effects rather than being generalizable to the entire Palestinian population.
When we examined CNVs and their impact on risk, we found no significant relationship between burden of homozygous deletions and risk, consistent with our results for inbreeding more generally. However, large duplications were associated with increased risk for SA and for the broader phenotype. Large CNVs have been previously found to increase the risk for schizophrenia (Kirov et al., 2009) , recurrent depression (Rucker et al., 2013) , and treatment-resistant depression (O'Dushlaine et al., 2014) . However, other studies show no evidence for the effect of rare large CNV burden in recurrent depression and lower rates of large CNVs in cases with bipolar disorder compared with controls (Grozeva et al., 2010 (Grozeva et al., , 2013 Rucker et al., 2016) .
Of particular interest, we find a CNV on chromosome 9p24.1 that appears to increase risk for SA with increased number of copies. This CNV covers GLDC, which encodes glycine dehydrogenase that binds to glycine and results in its degradation. Glycine is a co-agonist at N-methyl-D-aspartate glutamate receptors and thus increases glutamatergic neurotransmission. Plasma levels of glycine are found to be associated negatively with treatment response to the antidepressant citalopram and a SNP, rs10975641, in GLDC has been associated with treatment outcome (Ji et al., 2011) . In addition, plasma levels of the amino acid glycine are significantly increased in depressed patients (Mitani et al., 2006) , although other studies report no difference (Maes et al., 1998; Mauri et al., 1998) or lower glycine levels (Altamura et al., 1995; Sumiyoshi et al., 2004) . In our sample, only six (1.5%) participants reported the use of psychotropic medications and four of these were genotyped and did not carry a duplication or a deletion on chromosome 9p24.1. However, we did not collect information on history of treatment response and we did not measure glycine levels. The remaining sample reported that they did not use psychotropic medications (31.5%), did not know whether they used them (46%), or refused to answer this question (21%), which may reflect a cultural bias toward under-reporting the use of psychotropic medications. According to our results, and assuming that the GLDC gene is fully duplicated, the duplication should result in increased glycine degradation and consequently lead to decreased glycine levels. If the duplication were to interfere with gene function, however, it would reduce glycine degradation. A silent exonic GLDC splice mutation was described in a large consanguineous Bedouin kindred with an atypical milder form of glycine encephalopathy characterized by developmental delays, limited expressive speech, hypotonia, aggression, and irritability (Flusser et al., 2005) . Intriguingly, impulsive aggression is one of the important predictors of suicidal behavior (Melhem et al., 2007; Mann et al., 2009) . Glycine encephalopathy is also characterized by elevated levels of glycine concentrations in blood and cerebrospinal fluid and often treated with antagonists at the N-methyl-D-aspartate receptor site such as ketamine with well-established antidepressant properties (Van Hove et al., 2013; Zunszain et al., 2013) . A recent study reported SNPs in glutamatergic genes to be associated with SA (Sokolowski et al., 2013) . Given our results, it could be important to further examine the role of the GLDC gene in the risk for suicidal behavior.
Our findings add to the growing evidence of genetic risk factors that act pleiotropically to increase risk for several neuropsychiatric disorders, including depression and SA, irrespective of ancestry. Although our study is limited in sample size and its ability to examine the association of common and rare genetic variants to depression and SA, the results underscore the importance of CNVs not only for neurodevelopmental disorders but also for adult-onset disorders. This study shows several CNVs that could confer risk to depression and SA and a CNV in GLDC that specifically confers risk for SA. It could be important to elucidate the functional role of GLDC expression in risk suicidal behavior.
